3 ms·
From the article, it sounds like the weight loss, which leads to lower blood pressure. The approval is only for people with heart conditions AND obesity/overwe
by alistairSH 3y ago
From the article, it sounds like the weight loss, which leads to lower blood pressure. The approval is only for people with heart conditions AND obesity/overweight, not only a heart condition.
- giantg2 3y agoThe reason I asked is because this sounds like non-news. Like wasn't this the main benefit listed in the pharmaceutical review - reduction in vascular events/mortality by reducing weight? I was wondering if this was new research that showed an additional 20% reduction in groups with similar weight loss.
- alistairSH 3y agoI think the "heart condition" language is now explicit. The previous FDA approval[1] was for "management of obesity and at least one weight-treated condition" 1 - https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014 https://www.fda.gov/news-events/press-announcements/fda-appr...